Doug Bradley

Doug Bradley is an experienced professional with a successful career in the healthcare industry. Doug currently holds the position of VP of Global Marketing at Biofidelity, a company focused on providing accessible cancer diagnostics. Previously, Doug founded Market Access Group LLC, a consulting firm that partnered with early-stage companies to develop commercial strategies.

Prior to their role at Market Access Group LLC, Doug served as the VP of Global Marketing at Provista Diagnostics, where they led the commercial launch of their breast cancer diagnostic assay. Doug also worked as the VP of Marketing at Caris Life Sciences, a biosciences company specializing in genomic assays for cancer therapy identification.

Earlier in their career, Doug held the position of EVP of Global Marketing at Agendia, where they successfully grew revenue and market share by implementing effective Go-To-Market strategies. Doug also served in various marketing roles at Vertos Medical Inc, SenoRx, Inc., Obagi Medical Products, and Allergan.

Throughout their career, Doug has demonstrated expertise in commercial strategy, market validation, branding, and team-building. Doug has a strong track record of driving revenue growth and successfully launching disruptive technologies in the healthcare sector.

Doug Bradley holds a Bachelor's Degree in Microbiology from the University of Oklahoma. Doug then went on to earn a Master of Business Administration (M.B.A.) from Pepperdine University. Doug has also completed Merger Week and Strategic Alliances studies at Northwestern University's Kellogg School of Management. Doug further pursued Post Graduate Studies in Strategic Marketing at Columbia Business School and a Post Graduate Course in Negotiation Skills at Harvard University. Additionally, Doug obtained a certification in Inbound from HubSpot in November 2016.